Lower-Dose Extended Anticoagulation Just as Effective for VTE With Active Cancer

(MedPage Today) — CHICAGO — For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose — and safer, the API-CAT randomized trial…